Cancer chemoprevention is inhibition of neoplastic disease by naturally occurring or synthetic chemical agents. Dithiolethiones inhibit production of experimentally produced tumors by elevating the expression of several genes that encode for known cytoprotective enzymes. In an effort to discover additional molecular mechanisms mediating chemoprevention, cDNA clones representing a gene that is transcriptionally activated by dithiolethiones, hence named dithiolethione-inducible gene-1 (DIG-1), were isolated from rat liver via differential hybridization screening. The deduced amino acid sequence of DIG-1 was found to have 80% identity with the human liver enzyme leukotriene B 4 (LTB 4 ) 12-hydroxydehydrogenase. DIG-1, purified >400-fold from the liver of rats dosed with 1,2-dithiole-3-dithiolethione, possessed an NADP ⍣ -dependent activity to convert LTB 4 to 12-oxo-LTB 4 . Kinetic analysis of DIG-1 revealed apparent K m and V max values of 28 mM and 8
Introduction
Cancer chemoprevention is a prophylactic strategy wherein specific chemical agents are administered to prevent tumorigenesis (for a review see 1). One class of compounds that exhibit cancer chemopreventive activity are the dithiolethiones (for a review see 2). Dithiolethiones, which have been found as constituents of cruciferous vegetables, and their synthetic analogs inhibit tumorigenesis elicited by numerous structurally diverse carcinogens, such as aflatoxin B 1 , 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine, azoxymethane, benzo[a]pyrene and many others (for a review see 3) . One mechanism that has been proposed to account for this broad-based inhibition of carcinogenesis is induction of carcinogen metabolizing enzymes by dithiolethiones (3) . Activities of glutathione S-transferases, UDP-glucuronosyltransferases, NAD(P)H: quinone reductase, aflatoxin B 1 -aldehyde reductase and epoxide hydrolase have been shown to be enhanced in response to administration of dithiolethiones (for a review see 4). Elevation of activities of these enzymes typically serve to detoxify reactive electrophilic intermediates of carcinogens, thereby lowering their biologically effective dose. Expression of the genes encoding these carcinogen detoxification enzymes was found to be activated at the transcriptional level (4, 5) . This concerted induction of genes encoding detoxification enzymes suggests that dithiolethiones trigger a complex sequence of events that are ultimately cytoprotective in nature.
In an effort to facilitate an understanding of the complex combination of factors that result in cancer chemoprevention a molecular genetic approach was initiated to define the component genes involved in inhibition of tumorigenesis in response to administration of dithiolethiones. By differential hybridization screening cDNAs representing classes of genes not previously associated with cancer chemoprevention were found in rat hepatic tissues following administration of 1,2-dithiole-3-thione (D3T*). Multiple cDNA clones for the light and heavy subunits of ferritin were isolated (5) . The ferritin genes were found to be transcriptionally activated, implying coordination of regulation of ferritin genes with other dithiolethione-responsive genes (5, 6) . Elevations in the levels of ferritin correlated with decreased amounts of chelatable iron in rat hepatic tissues (6) . Iron, mobilized into the newly synthesized ferritin, is sequestered from participating in Fentontype reactions so that production of hydroxyl radicals may be diminished. Isolation and characterization of the induced activity of ferritin in response to dithiolethiones suggested that proteins other than carcinogen detoxification enzymes contribute to chemoprevention.
In addition to cDNA clones for ferritin, three cDNA clones encoding a gene that did not match any characterized cDNA sequence in the Genbank database were isolated (5). The RNA transcripts for these clones were highly induced by a chemopreventive dose of D3T in vivo (5) and, hence, were named dithiolethione-inducible gene-1 (DIG-1). The levels of RNA transcripts for DIG-1 were induced~20-fold by D3T through a transcriptional mechanism (5). The deduced amino acid sequence from the DIG-1 cDNA clones contained a NADPH binding site, with 30-70% identity to evolutionarily distant reductases and dehydrogenases (5) . These results suggested that DIG-1 may then function as a dithiolethioneresponsive oxidoreductase that may act to detoxify carbonylcontaining carcinogens.
In this report we present evidence that DIG-1 is a leukotriene B 4 12-hydroxydehydrogenase (LTB 4 DH) and that DIG-1 purified from the liver of rats dosed with D3T possesses activity to inhibit the chemotactic and superoxide anion releasing activities of leukotriene B 4 (LTB 4 ). The results of these investigations imply that induction of DIG-1 by dithiolethiones and subsequent catabolism of LTB 4 may account for additional mechanisms of cancer chemoprevention by suppression of inflammatory stimuli that contribute to tumor initiation and promotion.
Materials and methods
Materials LTB 4 and 13(S)-hydroxyoctadeco-9Z,13E-dienoic acid (13-HODE) were purchased from Oxford Biomedical (Rochester Hills, MI). Luminol and lucigenin were purchased from Sigma (St Louis, MO). D3T was provided by Dr Thomas J.Curphey (Dartmouth Medical School, Hanover, NH). Resins used for purification of DIG-1 were purchased from Pharmacia (Piscataway, NJ). Chemotaxis chambers equipped with 8 mm polycarbonate membranes were purchased from NeuroProbe (Cabin John, MD). All other reagents were of the highest quality purchased from Sigma Chemical Co. (St Louis, MO).
Animals and treatments
Male F344 rats, 100 g, were obtained from Harlan (Indianapolis, IN) and housed under controlled conditions of temperature, humidity and lighting. Food and water were available ad libitum. Purified diet of the AIN-76A formulation without the recommended addition of 0.02% ethoxyquin was used. Rats were acclimated to this diet for 1 week before beginning the experiments. For purification of DIG-1 rats were treated by gavage with 0.5 mmol/kg D3T given in 200 µl suspensions consisting of 1% Cremaphor (BASF Wyandotte Inc., Parsippany, NJ) and 25% glycerol in distilled water and then killed 24 h after dosing.
Alignment of amino acid sequences
Comparison of the aligned consensus amino acid sequences of rat liver DIG-1 and human liver LTB 4 DH deduced from their cDNA clones was performed using the Geneworks™ v.2.2.1 amino acid sequence alignment program (Intelligenetics, Mountain View, CA).
Analysis of LTB 4 and LTB 4 metabolites
Metabolism of LTB 4 was performed as described by Yokomizo et al. (7) with minor modifications. The reaction was initiated by adding 3 nmol LTB 4 in 2-86 µl 0.5ϫ phosphate-buffered saline (PBS), 2 µl fresh 1 mM NADP ϩ and 10 µl enzyme solution. The reaction was incubated in the dark for 0.25-1 h at 37°C in an Eppendorf thermomixer set at medium speed. The reaction was stopped by adding 200 µl ice-cold internal standard solution containing 0.4 nmol 13-HODE in ethylacetate. The solution was vortexed three times for 5 s and the phases separated by centrifugation at 10 000 g for 5 min at 4°C. An aliquot (150 µl) of the top layer containing LTB 4 and its metabolites was removed and dried. LTB 4 and its metabolites were resuspended in 100 µl mobile phase (50:50:0.1 acetonitrile:water:formic acid), injected onto a Vydac ODS column (4.8ϫ250 mm) and separated over a 25 min interval using a flow rate of 1 ml/min. LTB 4 and its metabolites were detected on a Hewlett-Packard diode array detector monitoring at 235 nm (internal standard and LTB 4 ) and 320 nm (12-oxo-LTB 4 ). Amounts of 12-oxo-LTB 4 were calculated from the extinction coefficient of 41 000/M/cm at 320 nm (8) using Hewlett Packard Chemstation software. Samples were normalized by dividing nmol internal standard calculated for each sample by the overall lowest observed amount of internal standard. Corrected amounts of 12-oxo-LTB 4 were determined by multiplying by this normalizing factor. Protein content was determined using the Pierce bicinchoninic acid protein assay with bovine serum albumin as standard. Linear initial velocities were obtained 0.25 h after the start of each reaction containing 0.25 mg purified DIG-1/ LTB 4 DH and a range of LTB 4 concentrations (0.25-30 mM). Apparent Michaelis-Menten constants K m and V max were determined by LineweaverBurk analysis.
Liquid chromatography mass spectrometric (LC/MS) analysis of LTB 6 metabolites
LC/MS was performed on a Hewlett Packard Chemstation equipped with a J-sphere ODS column (2ϫ250 mm) from YMC (Wilmington, NC) and a Finnegan TSQ1000 mass spectral detector (San Jose, CA). HPLC was performed as described above. Mass detection was achieved utilizing negative ion electrospray with a mass scan range of 150-750 a.u.
Purification of DIG-1 DIG-1/LTB 4 DH was purified from liver obtained from male F344 rats 24 h after gavage with 0.5 mmol/kg D3T essentially as described by Yokomizo et al. (7) . Cytosol (fraction I) was prepared from 50 g homogenized rat liver by established procedures (9) . Proteins were concentrated by ammonium sulfate precipitation and the fraction between 40 and 70% saturation (fraction II) was further purified. The fraction was resuspended and dialyzed against 10 mM sodium phosphate buffer, pH 8.0 (4°C), 1 mM dithiothreitol and 0.1 mM phenylmethylsulfonyl fluoride (buffer A). Fractions containing DIG-1/LTB 4 DH activity to produce 12-oxo-LTB 4 were analyzed as described above. Dialyzed fraction II was passed over a Q-Sepharose (Pharmacia) column (1ϫ30 cm) equilibrated with buffer A and the fractions containing DIG-1/LTB 4 DH flowed through the column and were pooled (fraction III). This fraction was subjected to cationic exchange chromatography using a S-Sepharose (Pharmacia) column (1ϫ30 cm). The proteins bound to the S-Sepharose column were eluted with a gradient of 0-1 M NaCl in buffer A. The fractions containing LTB 4 DH activity were pooled (fraction IV) and further purified by hydrophobic interaction chromatography on a phenylSepharose (Pharmacia) column (1ϫ30 cm). The protein in fraction IV was brought to 1.5 M ammonium sulfate by adding an equal volume of 3 M ammonium sulfate and this solution was added to the phenyl-Sepharose (Pharmacia) column equilibrated with 1.5 M ammonium sulfate. The fractions containing LTB 4 DH activity were eluted from this column using a 1.5-0 M gradient of ammonium sulfate. These were pooled (fraction V), concentrated to 0.5 ml and subjected to gel filtration chromatography on a Sephacryl-200 (Pharmacia) column equilibrated with buffer A. Protein eluting from the column with a molecular size of 35 kDa was collected and analyzed for activity. These fractions were pooled (fraction VI) and further purified by affinity chromatography on a 5 ml Hi-Trap Blue Sepharose Cibacron blue dye binding resin (Pharmacia). This resin selectively binds nucleotide cofactor-dependent enzymes. The bound fraction (fraction VII) containing DIG-1/LTB 4 DH was eluted with a 0-1.0 M NaCl gradient. Peak fractions containing the purified DIG-1/LTB 4 DH were pooled and analyzed for purity by SDS-PAGE and the molecular size and isoelectric point of DIG-1/LTB 4 DH were determined using gel filtration chromatography and non-equilibrium pH gel electrophoresis, as previously described by Primiano and Novak (9) .
N-Terminal amino acid microsequencing was performed by the Genetic Resources Core Facility of the School of Medicine, Johns Hopkins University. Automated Edman degradation was on 0.1 nmol purified DIG-1/LTB 4 DH using an Applied Biosystems gas-phase sequenator (Model 470) with on-line HPLC and a Nelson analytical chromatography data system (10).
Isolation of human neutrophils
The granulocytic fraction from 50 ml whole blood was freshly isolated from a healthy volunteer following standard procedures (11) . Briefly, whole blood was diluted 1:2 with RPMI medium and centrifuged at 900 g for 30 min at 4°C through a layer of sterile Ficoll-Paque. Contaminating erythrocytes were removed from neutrophils which sedimented to the bottom layer by lysing the cells with water for 1 min. The cell suspension was brought to 0.9% saline and centrifuged at 1500 g for 10 min at 4°C and the cell pellet washed with sterile PBS. This procedure was repeated three times to remove all erythrocytes. The number of viable neutrophils, usually 50ϫ10 6 cells, was determined by counting the number of cells that excluded trypan blue in a hemacytometer. 4 LTB 4 -stimulated chemotaxis was assessed by migration of freshly isolated human neutrophils through a cellulose acetate membrane with 8 mm pores in a modified Boyden chamber by the method of Penno et al. (12) . LTB 4 at concentrations ranging from 0.01 to 1000 nM was incubated with or without 0.02 U purified DIG-1/LTB 4 DH at 37°C for 1 h in 0.5ϫ PBS. Following incubation the LTB 4 -containing reaction mixture was placed in the bottom chamber and 50 000 neutrophils washed in PBS in the top. Cells were allowed to migrate along the chemotactic gradient for 3 h. The numbers of neutrophils that migrated into the bottom chambers were determined by measuring the intensity of fluorescence emission by Alamar blue at 590 nm, after excitation at 530 nm, using a Cytofluor measurement system (Millipore, Bedford, MA). The results obtained from duplicate samples of two separate experiments were averaged. Significant differences in the mean (P Ͻ 0.05) of the fluorescence intensity for a reaction containing one concentration of LTB 4 with enzyme versus its corresponding reaction lacking enzyme was performed using Student's t-test. 4 Lucigenin and luminol were used to monitor the respiratory burst of isolated neutrophils as described by Trush et al. (13) . LTB 4 (1500 nM) was incubated with 0, 0.01 or 0.02 U DIG-1/LTB 4 DH and 2 mM NADP ϩ for 30 min at Comparisons were performed using the Geneworks program for sequences found in Genbank with accession nos D49387 and U66322 (an updated sequence for DIG-1 shown in Figure 1 was deposited into Genbank with accession no. U66322) for human and rat enzymes respectively. 37°C in 100 ml 0.5ϫ PBS. The entire reaction mixture was added to neutrophils (1ϫ10 6 cells) suspended in a total volume of 1 ml PBS containing 0.5 mM MgCl 2 , 0.7 mM CaCl 2 and 0.1% glucose at 37°C. An aliquot (5 ml) of lucigenin or luminol (5 mM) was added immediately before analysis of the CL response, which was continuously measured for 0.5 h at 37°C in a Berthold LB9505 luminometer (Nashua, NH). CL responses from incubations of neutrophils, 2 U DIG-1/LTB 4 DH and 2 mM NADP ϩ , but lacking LTB 4 , were used as controls. An equivalent amount (0.25 mg) of bovine serum albumin was added instead of enzyme as a control. Integrated areas under the curve for the intensity of CL measured over 0.5 h were determined for each treatment group. Significant differences in the means (P Ͻ 0.05) between treament groups were analyzed by one way ANOVA and Bonferoni's multiple comparison test.
Measurement of chemotactic activity of isolated neutrophils in response to LTB

Measurement of reactive oxygen-derived chemiluminescence (CL) in isolated neutrophils in response to LTB
Results
DIG-1 encodes LTB 4 DH
In prior studies a cDNA clone for DIG-1 was isolated from a cDNA library constructed from mRNA isolated from liver of rats 24 h after treatment with 0.5 mmol/kg D3T (5) . An open reading frame of 987 nt starting with the Kozak consensus site was found. The deduced amino acid sequence had a length of 329 amino acids, yielding a calculated isoelectric point of 8.5 and molecular mass of~35 kDa. A recent search of the Genbank DNA database revealed that DIG-1 was related to a LTB 4 DH previously described from human liver (14) . Comparison of the deduced amino acid sequences of DIG-1 and LTB 4 DH from human liver revealed an identity of 80% over the available length of sequence (Figure 1) . The difference in length of human liver LTB 4 DH is because of the lack of nucleotide sequence from the cDNA clone isolated from human liver corresponding to the C-terminal portion of the protein (14) . The region spanning amino acids 134-190 of both sequences was found to be highly conserved for an NADP(H) binding site for dehydrogenases and reductases (5, 14) . This high degree of identity between the sequences shown in Figure  1 suggested that DIG-1 may encode a rat liver LTB 4 DH and is henceforth termed DIG-1/LTB 4 DH. Purification of DIG-1/LTB 4 DH LTB 4 DH purified from porcine liver cytosol has been shown to oxidize the 12-hydroxyl group of LTB 4 to a ketone (12-1001 oxo-LTB 4 ) (7). Conversion of LTB 4 to 12-oxo-LTB 4 has been demonstrated to be the first step in catabolism of LTB 4 , thereby diminishing its physiological actions (7, 8) . To investigate whether DIG-1/LTB 4 DH converts LTB 4 to 12-oxo-LTB 4 the enzyme was purified from the liver of male F344 rats gavaged with 0.5 mmol/kg D3T. DIG-1/LTB 4 DH was purified by ion exchange, dye binding and gel filtration chromatography to a Ͼ400-fold purification essentially as described by Yokomizo et al. (7) as shown in Table I . Purification of DIG-1/LTB 4 DH was followed by measuring conversion of LTB 4 to 12-oxo-LTB 4. A typical HPLC chromatogram showing production of 12-oxo-LTB 4 by the activity of purified DIG-1/LTB 4 DH is presented in Figure 2 . The relative retention time of 8.2 min for 12-oxo-LTB 4 was consistent with that observed by other investigators (7, 8) . The strong absorbance at 320 nm of 12-oxo-LTB 4 , due to the four conjugated double bonds, including the carbonyl group, was found for the peak with a retention time of 8.2 min (8) . A molecular weight of 334, determined by negative ion electrospray mass spectrometry, was consistent with identity of the product as 12-oxo-LTB 4 . Negative ion electrospray mass spectra of 12-oxo-LTB 4 were primarily found as the water-or sodium-adducted ions with masses [M -1 ] of 351 or 356 a.u. respectively (data not shown).
Peak fractions containing DIG-1/LTB 4 DH activity were pooled and analyzed for purity by SDS-PAGE and a single band representing purified DIG-1/LTB 4 DH is shown in Figure  3 , lane 8. The protein in this fraction was determined by gel filtration chromatography to have a molecular size of 35 kDa and to have an isoelectric point of 8.5 by non-equilibrium pH gel electrophoresis (data not shown). The purity and identity of DIG-1/LTB 4 DH were confirmed by N-terminal amino acid sequencing. The first 20 residues, MVQAKTWTLKKHF-EGFPTDS, corresponded exactly to the deduced sequence from the cDNA for DIG-1/LTB 4 DH (Figure 1) .
Kinetic analysis of the activity of purified DIG-1/LTB 4 DH toward LTB 4 was measured. Michaelis-Menten constants for the apparent K m (28 mM) and V max (8.1 nmol 12-oxo-LTB 4 produced/min/mg protein) were determined by LineweaverBurk analysis. 12-oxo-LTB 4 was not formed when either NAD ϩ , NADH or NADPH was used as the cofactor in the incubations (data not shown), therefore demonstrating the strict requirement for NADP ϩ by DIG-1/LTB 4 DH for its dehydrogenase activity. 4 DH LTB 4 is a potent stimulator of chemotaxis for pro-inflammatory cells, such as neutrophils, to sites of inflammation (15) . To examine whether DIG-1/LTB 4 DH could suppress chemotaxis by metabolism of LTB 4 migration of neutrophils in a modified Boyden chamber was analyzed. LTB 4 (0.01-1000 nM) stimulated neutrophil migration in a dose-dependent manner with an EC 50 of~1 nM (Figure 4) . Incubation of 0.1-1000 nM LTB 4 with 0.02 U purified DIG-1/LTB 4 DH, an amount (0.25 µg) of enzyme that converts 0.02 nmol/min at 37°C, substantially reduced LTB 4 -stimulated dose-dependent migration of neutrophils (Figure 4) . Inhibition of chemotactic migration of neutrophils by pre-incubation of LTB 4 with DIG-1/LTB 4 DH was found, as evidenced by the 2.0-to 3.5-fold decreased fluorescence intensity over the 10-1000 nM range in LTB 4 concentration. These decreases in mean fluorescence intensity were found to be statistically significant (n ϭ 4, P Ͻ 0.05) for 10-1000 nM concentrations. a Units are defined as nmol 12-oxo-LTB 4 formed/min for 1 h incubation at 37°C using 30 mM LTB 4 . 4 and its metabolite 12-oxo-LTB 4 generated by the activity of DIG-1/LTB 4 DH. Shown is an HPLC chromatogram depicting production of 12-oxo-LTB 4 generated by DIG-1/LTB 4 DH purified from rat hepatic cytosol. LTB 4 and the internal standard, 13-HODE, were detected by their absorbance at 235 nm (solid line) and 12-oxo-LTB 4 by its absorbance at 320 nm (dashed line). An aliquot (0.25 µg) of purified DIG-1/LTB 4 DH was incubated with 30 mM LTB 4 , 1 mM NADP ϩ in PBS at 37°C for 1 h. The peaks representing LTB 4 and 12-oxo-LTB 4 were separated using reverse phase HPLC and a 50% acetonitrile isocratic system with a flow rate of 1 ml/min.
Inhibition of LTB 4 -stimulated chemotaxis of human neutrophils by DIG-1/LTB
Fig. 2. HPLC profile of LTB
Inhibition of LTB 4 -stimulated reactive oxygen generation in human neutrophils by DIG-1/LTB 4 DH
Higher concentrations (Ͼ100 nM) of LTB 4 stimulate production of reactive oxygen species by granulocytic cells (16) . To examine whether DIG-1/LTB 4 DH could suppress reactive oxygen production in human neutrophil assays using luminol or lucigenin as chemiluminescent probes for reactive oxygen were performed. Lucigenin-derived CL is reflective of the level of superoxide anions produced by neutrophils. In contrast, luminol-derived CL is more reflective of involvement of Table I were loaded in each lane.
myeloperoxidase activity and hydrogen peroxide produced by neutrophils. A higher concentration of LTB 4 (150 nM) than that used for chemotactic experiments was found to be necessary to stimulate production of superoxide anions by neutrophils ( Figure 5 ). Lucigenin-derived CL measured over 0.5 h was elevated~2-fold as compared with cells in incubations not containing LTB 4 (control), as shown in Figure 5A . Preincubation of LTB 4 with 0.01 or 0.02 U DIG-1/LTB 4 DH inhibited LTB 4 -stimulated production of reactive oxygen by human neutrophils. Lucigenin-derived CL was dramatically decreased by pre-incubation of LTB 4 with 0.01 or 0.02 U enzyme, as shown in Figure 5A . The mean integrated areas under the curve shown in Figure 5A for lucigenin-derived CL were decreased 1.4-and 2.0-fold following addition of reactions containing 0.01 and 0.02 U DIG-1/LTB 4 DH respectively. These decreases were found to be statistically different (P Ͻ 0.05), as assessed using ANOVA and Bonferroni's multiple comparison test. A much less robust increase (1.2-fold) in levels of luminol-derived CL was stimulated by 150 nM LTB 4 , as shown in Figure 5B . However, upon addition of 0.01 or 0.02 U DIG-1/LTB 4 DH to the reaction, corresponding levels of CL diminished by 2.0-and 2.4-fold respectively. These results show that addition of DIG-1/LTB 4 DH inhibits LTB 4 simulation of reactive oxygen production by neutrophils. Apparently, increasing the amount of DIG-1/LTB 4 DH by just 2-fold significantly decreased the levels of reactive oxygen species produced by neutrophils, as assessed by either lucigenin-or luminol-derived CL. Interestingly, the levels of reactive oxygen species measured by lucigenin-or luminolderived CL in reactions from samples pre-incubated with 0.02 U purified DIG-1/LTB 4 DH were lower than the levels measured in control reactions.
Discussion
In this report we describe identification of DIG-1 as a LTB 4 DH. This conclusion was based on evidence from the alignment of amino acid sequences deduced from the cDNA clones for rat liver DIG-1 and human liver LTB 4 DH (5, 14) . A calculated identity of 80% was observed for the overlapping regions between the two sequences. Mutational analysis of human LTB 4 DH revealed that the glycine residues forming the nucleotide cofactor binding site, similar to that found in DIG-1 (14) , were essential for activity. Subsequent purification of DIG-1/LTB 4 DH from rat liver and demonstration of its activity to convert LTB 4 to 12-oxo-LTB 4 , as evidenced by mass spectral, HPLC and UV absorbance data, further supported the conclusion that DIG-1 is the rat ortholog of LTB 4 DH from human liver. N-terminal amino acid sequencing of purified DIG-1 confirmed its identity and the enzyme was then termed DIG-1/LTB 4 DH. Like its human ortholog, DIG-1/LTB 4 DH required NADP ϩ as a cofactor to catalyze production of 12-oxo-LTB 4 . DIG-1/LTB 4 DH from rat liver and LTB 4 DH from porcine kidney and human liver have comparable activities, as evidenced by similar V max (8-10 nmol/min/mg protein) and K m (25-40 mM) values (5, 7, 14) . Yokomizo et al. (7) found that a cytosolic LTB 4 DH was the initial enzyme in metabolism of LTB 4 in cytosolic fractions from porcine kidney. 12-oxo-LTB 4 is reduced by NAD(P)H-dependent reductases to 10,11-dihydro-12-oxo-LTB 4 and 10,11,14,15-tetrahydro-12-oxo-LTB 4 . Incubating NADH or NADPH with cytosolic prepara-tions from cultured kidney and liver cells failed to convert LTB 4 to 10,11-dihydro-12-oxo-LTB 4 and 10,11,14,15-tetrahydro-12-oxo-LTB 4 (17, 18) . These last results agree with the strict requirement for NADP ϩ by DIG-1/LTB 4 DH purified from rat liver. A similar reductive pathway is considered to be the major metabolic pathway for LTB 4 in cells other than neutrophils, based on the fact that 10,11-dihydro-LTB 4 is the major metabolite found upon incubation of tissue extracts with LTB 4 . Therefore, formation of 12-oxo-LTB 4 by DIG-1/LTB 4 DH, which utilizes NADP ϩ , is proposed as the initial step in LTB 4 metabolism in mammalian tissues. Further evidence in support of this proposal is that RNA transcripts for LTB 4 DH were highly expressed in human liver, kidney, small intestine and colon (14) . LTB 4 DH may function as part of the LTB 4 catabolic pathway in these tissues. It is then of interest to determine the role of this pathway in catabolism of LTB 4 and its impact on LTB 4 -mediated physiological processes. LTB 4 is a potent mediator of neutrophil adhesion, aggregation, chemotaxis and activation. Cellular damage triggered by chemical insult or pathogenic infection initiates the inflammatory response in tissues (19) . Several signals released from damaged or infected tissue, such as tumor necrosis factor α and interleukins 1 and 8, as well as various chemokines, stimulate arachadonic acid metabolism to produce prostaglandins, thromboxanes and leukotrienes (for a review see 20) . LTB 4 is produced by resident macrophages, primary granulocytic cells (i.e. neutrophils) and parenchymal cells within the infected tissue. Chemotactic recruitment of circulating neutrophils is enhanced by this released LTB 4 (15) . LTB 4 stimulates chemotaxis of neutrophils through interaction with a specific receptor. The LTB 4 receptor activates a pertussissensitive G protein, that in turn elevates calcium mobilization from intracellular stores through the actions of phopholipase C products (20) . Increased calcium concentrations stimulate cytoskeletal propulsion of the neutrophil along the LTB 4 chemotactic gradient. At higher concentrations (Ͼ100 nM) LTB 4 stimulates production of reactive oxygen species from neutrophils (16) . LTB 4 activates a respiratory burst within the accumulated neutrophils, resulting in increased production of reactive oxygen species at the site of inflammation (16, 21, 22) . These reactive oxygen species and proteases released from degranulated neutrophils kill pathogenic organisms. Alternatively, LTB 4 -stimulated release of nitric oxide, peroxides and superoxide anions by neutrophils that have migrated to sites of inflammation result in localized damage to affected tissues (23) (24) (25) .
Our results demonstrate that catabolism of LTB 4 to 12-oxo-LTB 4 by DIG-1/LTB 4 DH dramatically reduces the proinflammatory actions of LTB 4 . An active range of concentrations of LTB 4 (10-1000 nM) was found to increase chemotactic migration of neutrophils. Similar dose-response effects were found in COS7 cells transfected with a LTB 4 receptor cDNA expression construct (26) . We infer from the activity of DIG-1/LTB 4 DH that LTB 4 is oxidized to 12-oxo-LTB 4 , dramatically reducing chemotactic migration of human neutrophils. These findings may be related to those of Yokomizo et al. (7) , who demonstrated that 12-oxo-LTB 4 was 100-fold less active than LTB 4 in stimulating calcium mobilization in human neutrophils. Since 12-oxo-LTB 4 has been demonstrated to block the LTB 4 receptor (14) , it is therefore likely that 12-oxo-LTB 4 generated by the activity of DIG-1/LTB 4 DH from rat liver inhibits chemotactic migration of neutrophils by blocking the LTB 4 receptor.
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LTB 4 stimulated production of superoxide anions by human neutrophils, as evidenced by increased lucigenin-derived CL. In contrast, LTB 4 only marginally enhanced the observed luminol-derived CL. Lucigenin-derived CL is reflective of the generation of superoxide anions by NADPH oxidase. On the other hand, luminol-derived CL is indicative of hydrogen peroxide-dependent oxidation of luminol by myeloperoxidase, which is usually associated with secretory granules of neutrophils (13) . These results agree with those demonstrating that LTB 4 is a poor secretagogue (16) . Incubating LTB 4 with DIG-1/LTB 4 DH, putatively resulting in formation of 12-oxo-LTB 4 , decreased the observed lucigenin-and luminol-derived CL produced by neutrophils to levels lower than those seen for non-stimulated neutrophils. These results may be interpreted as 12-oxo-LTB 4 inhibiting basal levels of reactive oxygen production by blocking constitutive production of LTB 4 within neutrophils. Direct control of reactive oxygen production by the LTB 4 receptor has not been demonstrated. However, because 12-oxo-LTB 4 acts as a LTB 4 receptor antagonist, it is plausible that reactive oxygen production in neutrophils is mediated by the LTB 4 receptor. Alternatively, 12-oxo-LTB 4 may block LTB 4 synthesis, thereby leading to the observed decrease in production of reactive oxygen species by neutrophils.
Abundant evidence exists linking inflammation and cancer (27) . Epidemiological studies indicate that chronic inflammation associated with ulcerative colitis, gastritis or hepatitis manifested during bacterial, parasitic or viral infections has been linked to increased risks for development of malignant neoplasms (28) (29) (30) . A notable example is the observation that individuals with clinically assessed inflammatory bowel disease have higher risks of developing colorectal tumors (28) . Increased levels of LTB 4 are found at sites of inflammation and tumor formation (31) . Therefore, LTB 4 -stimulated neutrophil migration and activation may be important in the etiology of certain cancers. Neutrophils present at sites of chronic infection are stimulated to release highly reactive oxidants, such as hydrogen peroxide, superoxide anions, nitric oxide and peroxynitrite (21, 22) . Such oxidative events leading to mutagenesis and cytotoxicity are associated with tumor promotion (32, 33) . These reactive products of neutrophils produce DNA strand breaks and sister chromatid exchange in neighboring cells (23) (24) (25) . Additionally, neutrophils also enhance oxidation of carcinogens to highly reactive metabolic intermediates (34, 35) . Consequently, blocking formation of LTB 4 or enhancing its catabolism may afford protection from tumorigenesis. Moreover, additional evidence indicates that blocking the pathway for synthesis of LTB 4 can inhibit or reverse the tumorigenic process (36) . Experiments using curcumin, a natural compound capable of inhibiting 5-lipoxygenase, showed decreased tumor promotion by phorbol ester in the mouse skin tumor model (36) .
As an alternative to blocking LTB 4 synthesis to suppress its pro-inflammatory effects is to enhance its degradation. The levels of RNA transcripts of DIG-1/LTB 4 DH are elevated~20-fold by a single dose of D3T. DIG-1/LTB 4 DH is the first enzyme in the degradative pathway found in tissues other than neutrophils. Elevating expression of this enzyme may then increase inactivation of LTB 4 . Consequently, induction of DIG-1/LTB 4 DH by dithiolethiones or other chemopreventive agents in vivo may afford protection from untoward tissue or organ damage by suppressing LTB 4 -mediated inflammatory processes. We hypothesize that dithiolethiones, in addition to inducing genes of enzymes that enhance metabolism of carcino-gens, act to inhibit tumorigenesis by increasing metabolism of LTB 4 .
